Cases 11 - 20 of 262
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Astellas Pharma Inc. et al v. Sandoz Inc. et al
as 1:2020cv01589
Defendant:
Sawai Pharmaceutical Co., Ltd., Cadila Healthcare Ltd. doing business as Zydus Cadila, Apotex Inc. and others
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Teva Pharmaceuticals International GmbH et al v. BendaRx Corp.
as 1:2023cv00633
Plaintiff:
Teva Pharmaceuticals International GmbH, Cephalon, LLC and Eagle Pharmaceuticals, Inc.
Defendant:
BendaRx Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2023cv00551
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Teva Pharmaceuticals International GmbH et al v. BendaRx Corp.
as 1:2023cv00490
Plaintiff:
Teva Pharmaceuticals International GmbH, Cephalon, LLC and Eagle Pharmaceuticals, Inc.
Defendant:
BendaRx Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie, Inc. v. Teva Pharmaceuticals, Inc.
as 1:2023cv00374
Plaintiff:
AbbVie Inc.
Defendant:
Teva Pharmaceuticals Industries Ltd. and Teva Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie, Inc. v. Teva Pharmaceuticals, Inc.
as 1:2023cv00362
Plaintiff:
AbbVie Inc.
Defendant:
Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff:
AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant:
Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Anacor Pharmaceuticals, LLC, et al., v. Dr. Reddys Laboratories, Ltd., et al.,
as 1:2021cv01348
Plaintiff:
Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V. and Anacor Pharmaceuticals, LLC
Defendant:
Alkem Laboratories Ltd., Dr. Reddys Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals U.S.A., Inc.
as 1:2023cv00152
Plaintiff:
Vanda Pharmaceuticals Inc.
Defendant:
Teva Pharmaceuticals U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
